Wellgistics Health, Inc. · NASDAQ:WGRX

Wellgistics Health, Inc. financial statements

Wellgistics Health, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022
Revenue23.3M18.1M032.8M
Cost of revenue33.0M16.4M027.0M
Gross profit-9.64M1.77M05.75M
Research and development3751.40K
Selling, general and administrative70.3M6.80M2.88M7.08M
Operating income-81.2M-6.15M-2.88M-3.42M
Depreciation and amortization192.2K1.11M02.09M
EBITDA-81.0M-5.03M-2.88M-1.34M
Interest expense4.58M831.5K15.1K287.2K
Income before tax-101.3M-6.86M-2.90M-2.74M
Net income-101.3M-6.86M-2.90M-2.74M
Earnings per share, basic-71.33-6.60-3.24-2.90

Balance sheet

LineFY2025FY2024FY2023FY2022
Cash and equivalents42.6K1.03M1.36K0
Receivables1.14M3.75M337.0K
Inventory1.64M9.52M0
Current assets2.82M15.2M338.4K0
Goodwill14.2M16.2M0
Total assets30.5M57.3M338.4K0
Accounts payable11.7M6.33M1.04M5.25K
Current liabilities29.8M38.0M2.89M5.25K
Long-term debt12.6M11.5M350.0K
Total debt24.8M25.1M700.0K
Total liabilities42.9M50.6M3.24M5.25K
Shareholders' equity-12.4M6.73M-2.90M-5.25K
Shares outstanding1.42M1.04M894.4K945.0K

Cash flow

LineFY2025FY2024FY2023FY2022
Cash from operations-10.9M-1.22M-349.1K0
Capital spending-881.5K-377.3K00
Free cash flow-10.9M-1.60M-349.1K0
Cash from investing-881.5K469.1K
Cash from financing10.8M1.78M350.5K0
Share buybacks2.84M
Change in cash-985.8K1.03M1.36K0